N-Acetylcysteine Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: N-Acetylcysteine evidence and protocol review

Longevity Research compound PowderCapsule needs_revision Best effort · source review pending

Also known as: NAC, Acetylcysteine

Open in Calculator ← Compound Index All Tools
Best-effort research profile: this record has not passed full two-source scientific verification. Descriptive fields, research protocols, storage/handling notes, and interaction guidance below are shown with their evidence labels, but calculator presets and exact dosing math remain hidden until the record is verified or reaches Community-Supported status.

Quick Facts

Reference Sizes
1 g, 10 g, 100 g
Storage
No approved consumer storage standard exists for this presentation; follow the lot-specific COA and validated stability data
Solubility
Water-soluble; dissolve directly

Best-Effort Research Profile

N-acetylcysteine (NAC) is an acetylated derivative of the amino acid cysteine, serving as a rate-limiting precursor for intracellular glutathione synthesis. It is FDA-approved as an antidote for acetaminophen (paracetamol) overdose and as a mucolytic in respiratory conditions, and has been studied in psychiatric research (e.g., for compulsive/addictive behaviors) as an adjunct.

Source review pending. This descriptive profile is shown from the available source material as a best-effort educational reference. It has not passed the full verification bar and is not a dosing instruction, medical claim, or treatment recommendation.

Research Profile

Half-Life
~6.25 hours (oral)
Onset
Acute antidote effect in overdose protocols; chronic dosing studied for psychiatric/respiratory research
Administration Routes (Research)
Intravenous (IV)OralInhaled

Reported Research Effects

Reported Research Side Effects

Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Route-Specific Research Protocols

Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.

Label / guideline Human study Community only Preclinical only Not established
Intravenous (IV) Label / guideline

150 mg/kg loading dose followed by label-directed maintenance infusions

Frequency / timing
Continuous staged infusion
Duration / setting
21-hour protocol
Technique
IV
Evidence
Regulatory label

Context: ACETADOTE prescribing information

Formulation: Route-specific sterile formulation and professional handling requirements apply; concentration cannot be inferred from an oral or topical product.

Route safety: Use only in the cited label or guideline context; route, formulation, indication, and patient-specific limits still apply.

Source 1
Oral Not established

No route-specific amount established in the reviewed record.

Technique
Oral
Evidence
Route noted; protocol not established

Context: The catalog identifies this route, but its reviewed sources do not establish a separate amount and schedule for it.

Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.

Route safety: No route-specific protocol is established. Do not infer an amount from another route, component, or formulation.

Source 1
Inhaled Not established

No route-specific amount established in the reviewed record.

Technique
Inhaled (mucolytic use)
Evidence
Route noted; protocol not established

Context: The catalog identifies this route, but its reviewed sources do not establish a separate amount and schedule for it.

Route safety: No route-specific protocol is established. Do not infer an amount from another route, component, or formulation.

Source 1

Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.

Research Notes

The IV acetaminophen-overdose protocol is indication-specific. Oral supplement trials use heterogeneous doses and do not inherit the IV antidote claim.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources Under Review

ACETADOTE acetylcysteine prescribing information — DailyMed (NIH)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2311c94-2b88-4b55-8e27-6a86ae4a7018

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Articles

Published articles on this site that mention N-Acetylcysteine or one of its catalog aliases.

Vitamin B1 Deficiency and Vision Loss in GLP-1 Users: What the New Evidence ShowsRead related research article Satoprodil Phase 2 Depression Trials: Why the GluN2B Strategy Failed to Beat PlaceboRead related research article GLP-1 Vision Loss Reports: B1 Deficiency and NAIONRead related research article FDA GLP-1 Generic Drug Workshop Clarifies Quality Questions for Semaglutide and TirzepatideRead related research article

Related Research Tools

Reconstitution CalculatorConcentration, draw volume, per-unit amounts Unit Convertermg, mcg, mL, units conversion Compound CompareSide-by-side comparison tool Cost CalculatorCost per mg, mcg, per-draw

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top